Bharat Parenterals (NSE:BPLPHARMA) Cyclically Adjusted Book per Share: ₹0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BPLPHARMA Bharat Parenterals Ltd NSE:BPLPHARMA
55 GF Score
Price ₹1,294.70
GF Value ₹1,232.25
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Bharat Parenterals Cyclically Adjusted Book per Share?

Bharat Parenterals NSE:BPLPHARMA +1.60% 55 Cyclically Adjusted Book per Share is ₹0.00 as of Jun. 2026. GuruFocus rates NSE:BPLPHARMA with a GF Score™ of 55/100 and a GF Value™ of ₹1,232.25 (Fairly Valued). The stock has 5 warning signs investors should review.

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Bharat Parenterals's adjusted book value per share for the three months ended in Jun. 2026 was ₹0.000. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Bharat Parenterals's average Cyclically Adjusted Book Growth Rate was 14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-21), Bharat Parenterals's current stock price is ₹1294.70. Bharat Parenterals's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was ₹0.00. Bharat Parenterals's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bharat Parenterals was 6.75. The lowest was 3.11. And the median was 3.94.


Bharat Parenterals  (NSE:BPLPHARMA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bharat Parenterals was 6.75. The lowest was 3.11. And the median was 3.94.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Bharat Parenterals Cyclically Adjusted Book per Share Related Terms


Bharat Parenterals Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Bharat Parenterals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bharat Parenterals Cyclically Adjusted Book per Share Chart

Bharat Parenterals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bharat Parenterals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:BPLPHARMA vs : Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bharat Parenterals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bharat Parenterals Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bharat Parenterals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bharat Parenterals's Cyclically Adjusted PB Ratio falls into.


NSE:BPLPHARMA
55GF Score
Bharat Parenterals Ltd NSE:BPLPHARMA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bharat Parenterals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bharat Parenterals's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/333.9520*333.9520
=0.000

Current CPI (Jun. 2026) = 333.9520.

Bharat Parenterals Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 111.134 243.801 152.228
201706 0.000 244.955 0.000
201709 0.000 246.819 0.000
201712 0.000 246.524 0.000
201803 127.135 249.554 170.131
201806 0.000 251.989 0.000
201809 0.000 252.439 0.000
201812 0.000 251.233 0.000
201903 164.062 254.202 215.533
201906 0.000 256.143 0.000
201909 179.564 256.759 233.549
201912 0.000 256.974 0.000
202003 206.263 258.115 266.865
202006 0.000 257.797 0.000
202009 237.347 260.280 304.528
202012 0.000 260.474 0.000
202103 251.075 264.877 316.551
202106 0.000 271.696 0.000
202109 279.564 274.310 340.348
202112 0.000 278.802 0.000
202203 287.143 287.504 333.533
202206 0.000 296.311 0.000
202209 306.494 296.808 344.850
202212 0.000 296.797 0.000
202303 316.530 301.836 350.209
202306 0.000 305.109 0.000
202309 334.089 307.789 362.488
202312 0.000 306.746 0.000
202403 338.947 312.332 362.409
202406 0.000 314.175 0.000
202409 434.166 315.301 459.848
202412 0.000 315.605 0.000
202503 479.789 319.799 501.023
202506 0.000 322.561 0.000
202509 480.267 324.800 493.800
202512 0.000 324.054 0.000
202603 467.546 330.213 472.840
202606 0.000 333.952 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₹0.00 mean?
Bharat Parenterals (NSE:BPLPHARMA) has a Cyclically Adjusted Book per Share of ₹0.00 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bharat Parenterals and its competitors.
Is Bharat Parenterals' Cyclically Adjusted Book per Share too high?
Bharat Parenterals' current Cyclically Adjusted Book per Share is ₹0.00. Overall, Bharat Parenterals has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bharat Parenterals' Cyclically Adjusted Book per Share compare to ?
Bharat Parenterals' Cyclically Adjusted Book per Share of ₹0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bharat Parenterals and its competitors. Bharat Parenterals's current Cyclically Adjusted Book per Share is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bharat Parenterals stock overvalued right now?
Based on GuruFocus' analysis, Bharat Parenterals (NSE:BPLPHARMA) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,232.25, compared to a current price of ₹1,294.70 — trading 5.1% above its estimated fair value. The current Cyclically Adjusted Book per Share is ₹0.00. Bharat Parenterals' overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Bharat Parenterals (NSE:BPLPHARMA), the current Cyclically Adjusted Book per Share is ₹0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bharat Parenterals (NSE:BPLPHARMA) Overvalued in 2026?

Based on GuruFocus' analysis, Bharat Parenterals stock appears to be overvalued. The current stock price of ₹1,294.70 is trading 5.1% above its estimated GF Value™ of ₹1,232.25. GuruFocus considers Bharat Parenterals to be Fairly Valued.

Key valuation signals for NSE:BPLPHARMA:

  • Cyclically Adjusted Book per Share: ₹0.00
  • GF Value™: ₹1,232.25 vs. price of ₹1,294.70 (5.1% above fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the NSE:BPLPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bharat Parenterals Business Description

Comparable Companies
Other Exchanges 541096:India
Address Survey No.144-A, Jarod Samlaya Road, Village Haripura, Tehsil Savli, Vadodara, GJ, IND, 391520
Bharat Parenterals Ltd is a pharmaceutical company. It provides various products such as Capsules, Dry Syrups, Sachets, Oral Liquids, Injections, Semisolids, and others. Geographically, the group has a business presence in India and Outside India.
55GF Score

Get the complete analysis for NSE:BPLPHARMA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,294.70
Price
₹1,232.25
GF Value